What's the outlook for DVAX's EPS growth?

**Dynavax Technologies (DVAX) is poised for a positive EPS growth outlook**, supported by several key factors: 1. **Consistent Revenue Growth**: Dynavax has demonstrated a consistent increase in revenue over the past quarters. This trend is a strong indicator of improved profitability, which often translates to higher EPS. 2. **Margin Improvements**: The company's net income has shown significant improvements, with a 232% increase in the second quarter of 2024 compared to the previous year. This increase in net income is a direct result of higher revenue and is reflected in the improved profit margin, which rose from 5.7% to 15%. 3. **Analyst Expectations**: Analysts have lifted their FY2024 EPS estimates for Dynavax Technologies, indicating a positive outlook on the company's earnings potential. 4. **Recent Performance**: Dynavax's recent earnings reports have exceeded expectations, with the company reporting quarterly earnings per share (EPS) of $0.05, beating the Zacks Consensus Estimate of $0.04. This recent performance sets a positive tone for future EPS growth. 5. **Strategic Initiatives**: The company's strategic initiatives, such as the uplisting to the Nasdaq Global Select Market, suggest a focus on enhancing its market position and profitability, which could positively impact EPS growth. In conclusion, Dynavax Technologies is likely to experience a positive EPS growth trajectory due to its consistent revenue growth, improved profit margins, analyst expectations, recent earnings outperformance, and strategic initiatives.